We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
-0.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$19B
AUM Growth
+$1.28B
(+7.2%)
Cap. Flow
+$1.55B
Cap. Flow
% of AUM
8.12%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
3,992
New
448
Increased
1,822
Reduced
816
Closed
180
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$89.1M |
| 2 |
WEX
WEX
|
+$78.4M |
| 3 |
Blackrock
BLK
|
+$73.2M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$71.9M |
| 5 |
OneMain Financial
OMF
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$63.6M |
| 2 |
Neurocrine Biosciences
NBIX
|
+$56.6M |
| 3 |
Agnico Eagle Mines
AEM
|
+$55.1M |
| 4 |
DFS
Discover Financial Services
DFS
|
+$36M |
| 5 |
ORBC
ORBCOMM, Inc.
ORBC
|
+$27.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.39% |
| 2 | Financials | 14.65% |
| 3 | Healthcare | 12.11% |
| 4 | Consumer Discretionary | 7.54% |
| 5 | Industrials | 6.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
iShares Russell 1000 Growth ETF
IWF
$121B
| $125M | 0.66% |
1,830,352
+138,816
| +8% | +$9.82M |
|
27
United Rentals
URI
$67.2B
| $123M | 0.65% |
350,573
+4,212
| +1% | +$1.41M |
|
28
iShares Russell 1000 Value ETF
IWD
$82.2B
| $116M | 0.61% |
743,770
+96,740
| +15% | +$15.5M |
|
29
Home Depot
HD
$331B
| $115M | 0.6% |
349,058
+57,408
| +20% | +$18.8M |
|
30
Walt Disney
DIS
$167B
| $113M | 0.6% |
669,811
+51,199
| +8% | +$9.13M |
|
|
31
Blackrock
BLK
$169B
| $113M | 0.59% |
134,243
+81,715
| +156% | +$73.2M |
|
32
NVIDIA
NVDA
$4.86T
| $109M | 0.57% |
5,279,630
+450,470
| +9% | +$9.35M |
|
33
Arch Capital
ACGL
$34.3B
| $109M | 0.57% |
2,849,890
+65,021
| +2% | +$2.58M |
|
|
34
WEX
WEX
$6.37B
| $107M | 0.56% |
608,169
+430,260
| +242% | +$78.4M |
|
35
PayPal
PYPL
$48.9B
| $105M | 0.55% |
405,176
+17,710
| +5% | +$5.02M |
|
36
Martin Marietta Materials
MLM
$31.5B
| $105M | 0.55% |
308,309
+1,488
| +0.5% | +$541K |
|
|
MPT
37
Medical Properties Trust
MPT
$2.77B
| $102M | 0.54% |
5,076,863
+13,298
| +0.3% | +$273K |
|
38
Invesco QQQ Trust
QQQ
$453B
| $96.6M | 0.51% |
269,947
+14,394
| +6% | +$5.3M |
|
39
iShares MSCI EAFE ETF
EFA
$78B
| $90.2M | 0.47% |
1,156,650
+36,034
| +3% | +$2.88M |
|
40
BioMarin Pharmaceuticals
BMRN
$11.6B
| $89M | 0.47% |
1,151,859
+338,406
| +42% | +$26.7M |
|
41
Costco
COST
$422B
| $88.2M | 0.46% |
196,345
+10,416
| +6% | +$4.58M |
|
42
Keysight
KEYS
$54.5B
| $85.5M | 0.45% |
520,681
+7,507
| +1% | +$1.26M |
|
|
43
Elanco Animal Health
ELAN
$13.2B
| $84.8M | 0.45% |
2,658,554
+2,654,046
| +58,874% | +$89.1M |
|
44
iShares Core MSCI EAFE ETF
IEFA
$190B
| $83.8M | 0.44% |
1,128,618
+140,755
| +14% | +$10.7M |
|
45
Cisco
CSCO
$457B
| $81.2M | 0.43% |
1,492,734
-4,156
| -0.3% | -$233K |
|
46
UnitedHealth
UNH
$376B
| $81.2M | 0.43% |
207,860
+14,126
| +7% | +$5.85M |
|
47
Thermo Fisher Scientific
TMO
$213B
| $79.5M | 0.42% |
139,133
+18,917
| +16% | +$10.4M |
|
48
Johnson & Johnson
JNJ
$618B
| $78M | 0.41% |
482,837
+43,095
| +10% | +$7.35M |
|
49
Ralph Lauren
RL
$22.6B
| $77M | 0.4% |
693,521
-3,593
| -0.5% | -$415K |
|
50
McDonald's
MCD
$192B
| $75.2M | 0.4% |
311,807
+36,681
| +13% | +$8.76M |
|
Similar funds
Rockefeller Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Rockefeller Capital Management held 3,992 positions worth $19B, up 7.2% from $17.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Rockefeller Capital Management deployed $1.55B of net new capital in Q3 2021, opening 448 new positions and adding to 1,822 existing holdings. Its largest new stake was Darling Ingredients: 56,725 shares worth $4.08M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $63.6M trimmed.
- Rockefeller Capital Management's largest Q3 2021 buy was Darling Ingredients: 56,725 shares worth $4.08M.
- Rockefeller Capital Management added most to Elanco Animal Health in Q3 2021, an estimated $89.1M increase.
- Rockefeller Capital Management's biggest Q3 2021 reduction was Regeneron Pharmaceuticals, cutting an estimated $63.6M.
- Rockefeller Capital Management fully exited ORBCOMM, Inc. in Q3 2021, selling an estimated $27.5M.
- Rockefeller Capital Management's ten largest holdings make up 20% of its $19B portfolio in Q3 2021.
- Rockefeller Capital Management opened 448 new positions and closed 180 in Q3 2021.
- Rockefeller Capital Management's portfolio value rose 7.2% quarter-over-quarter to $19B.
Based on Rockefeller Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.